Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase II Chemotherapy with MTX/CF, Aminopterin or M-BACOD plus CTX or BCG Immunotherapy for Advanced non-Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
25 to 65
DFCI-75116
Last Modified:
8/8/2008
 
First Published:
6/1/1999
2.
Phase II Study of Aminopterin in Patients With Refractory Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
Any age
Pharmaceutical / Industry
ILEX-AMT-002/1997
UTSMC-AMT-002/1997, UTSMC-FDR001458, NCI-V99-1534, NCT00003305
Last Modified:
7/1/2000
 
First Published:
5/1/1999
3.
Phase II Study of Aminopterin in Patients with Persistent, Recurrent, or Refractory Endometrial Carcinoma (Summary Last Modified 07/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
Not specified
Pharmaceutical / Industry
ILEX-AMT221-A1
ILEX-AMT221, NCI-V99-1531, NCT00003821
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute